NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Clinical trial NCT07052305 · RECRUITING

Trial details

NCT number: NCT07052305
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Large B-cell Lymphoma

Start date: 2026-03-12
Primary completion: 2027-11-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.